CM

Charlotte McDonagh

SG Seattle Genetics: 10 patents #13 of 101Top 15%
MP Merrimack Pharmaceuticals: 2 patents #37 of 75Top 50%
SE Seagen: 1 patents #52 of 95Top 55%
VB Vor Biopharma: 1 patents #8 of 15Top 55%
Overall (All Time): #330,423 of 4,157,543Top 8%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
12209135 Anti-CD45 antibodies and conjugates thereof Anthony Boitano, Michael Cooke, Rahul Palchaudhuri, Rajiv Panwar, Bradley R. Pearse +2 more 2025-01-28
11331394 CD19 binding agents and uses thereof Charles G. Cerveny, Dennis Benjamin, Paul Carter 2022-05-17
9919061 CD19 binding agents and uses thereof Charles G. Cerveny, Dennis Benjamin, Paul Carter 2018-03-20
9701752 Humanized anti-CD70 binding agents and uses thereof Paul Carter 2017-07-11
9428585 Humanized anti-CD70 binding agents and uses thereof Paul Carter 2016-08-30
9345766 Combination therapies comprising anti-ERBB3 agents Bo Zhang, Alexandra Huhalov 2016-05-24
9073993 CD19 binding agents and uses thereof Charles G. Cerveny, Dennis Benjamin, Paul Carter 2015-07-07
8927694 Human serum albumin linkers and conjugates thereof Michael Feldhaus, Alexandra Huhalov 2015-01-06
8562987 Humanized anti-CD70 binding agents and uses thereof Paul Carter, Julie McEarchern, Che-Leung Law 2013-10-22
8455622 Variant target binding agents and uses thereof Paul Carter, Django Sussman 2013-06-04
8257706 CD30 binding agents and uses thereof Paul Carter 2012-09-04
8242252 CD19 binding agents and uses thereof Charles G. Cerveny, Dennis Benjamin, Paul Carter, Hans-Peter Gerber, Leigh Francisco 2012-08-14
8067546 Humanized anti-CD70 binding agents and uses thereof Paul Carter, Julie McEarchern, Che-Leung Law 2011-11-29
7968687 CD19 binding agents and uses thereof Charles G. Cerveny, Dennis Benjamin, Paul Carter 2011-06-28